107 related articles for article (PubMed ID: 28941882)
1. Investigation of an algorithm for anti HCV EIA reactivity in blood donor screening in Turkey in the absence of nucleic acid amplification screening.
Karakoc AE; Berkem R; Irmak H; Demiroz AP; Yenicesu I; Ertugrul N; Arslan Ö; Kemahli S; Yilmaz S; Ozcebe O; Kara A; Ozet G; Acikgoz ZC; Acikgoz T
Transfus Apher Sci; 2017 Oct; 56(5):732-737. PubMed ID: 28941882
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
3. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
4. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
5. Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus.
Zhang K; Wang L; Sun Y; Zhang R; Lin G; Xie J; Li J
Transfus Med; 2014 Oct; 24(5):297-304. PubMed ID: 25262976
[TBL] [Abstract][Full Text] [Related]
6. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
[TBL] [Abstract][Full Text] [Related]
7. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
9. Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests.
Palacios A; Taylor L; Haue L; Luftig RB; Visoná KA
J Med Virol; 1999 Jul; 58(3):221-6. PubMed ID: 10447416
[TBL] [Abstract][Full Text] [Related]
10. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
11. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Tobler LH; Stramer SL; Lee SR; Masecar BL; Peterson JE; Davis EA; Andrews WE; Brodsky JP; Kleinman SH; Phelps BH; Busch MP
Transfusion; 2003 Oct; 43(10):1452-9. PubMed ID: 14507279
[TBL] [Abstract][Full Text] [Related]
12. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
13. A pilot study on screening blood donors with individual-donation nucleic acid testing in China.
Dong J; Wu Y; Zhu H; Li G; Lv M; Wu D; Li X; Zhu F; Lv H
Blood Transfus; 2014 Apr; 12(2):172-9. PubMed ID: 24333061
[TBL] [Abstract][Full Text] [Related]
14. Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.
Choudhury N; Tulsiani S; Desai P; Shah R; Mathur A; Harimoorthy V
Asian J Transfus Sci; 2011 Jan; 5(1):26-31. PubMed ID: 21572711
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between signal/cutoff ratios of anti-HCV enzyme immunoassay (EIA) and their true positivity in blood donors].
Ren FR; Gong XY; Li JJ; Lü QS; Liu CL; Zhuang H; Shan H; Wang JX
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):255-8. PubMed ID: 15850510
[TBL] [Abstract][Full Text] [Related]
16. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
[TBL] [Abstract][Full Text] [Related]
17. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan.
Niazi SK; Bhatti FA; Salamat N; Ghani E; Tayyab M
Transfusion; 2015 Jul; 55(7):1803-11. PubMed ID: 25648663
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
19. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
[TBL] [Abstract][Full Text] [Related]
20. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
